Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China.
Yue LiMengdie ZhangYi XuXin LiTao LuPublished in: International journal of clinical pharmacy (2024)
Low availability and affordability of anti-HBV drugs were observed. Policy recommendations should emphasize the improvement of LPG availability by incentivizing priority prescribing. Healthcare subsidies should be provided more effectively and equitably.